22 April 2025 : Original article
Simultaneous Liver and Kidney Transplant in a Middle-Income Country: A Single-Center Experience
Laura Peña-Blanco ACDEF 1, Paula Santamaría-Rodriguez ABCDEF 1,2, Susana Beltrán-Villegas BCDEF 1, Juan Sebastián Montoya-Beltrán
ADEF 1, Nataly A. Ramírez ADEF 3, Carlos A. Benavides ABDEF 3, Félix Ramón Montes ACDEF 1*
DOI: 10.12659/AOT.947649
Ann Transplant 2025; 30:e947649
Table 2 Intraoperative and in-hospital postoperative variables.
| Adults (n=31) | Pediatric (n=10) | |
|---|---|---|
| Duration of surgery, min | 531.8±100.8 | 507±133.9 |
| Hepatic cold ischemia, min | 388.9±121.6 | 377.4±128.8 |
| Anhepatic phase, min | 62.9±20.5 | 47.5±9.9 |
| Renal cold ischemia, min | 586.3±149 | 561.7±240.1 |
| Red blood cells | 26 (84%) | 10 (100%) |
| Platelets | 11 (35%) | 3 (30%) |
| Plasma | 15 (48%) | 7 (70%) |
| Cryoprecipitates | 9 (29%) | 1 (10%) |
| Cell saver | 5 (16%) | – |
| Red blood cells | 12 (38%) | 3 (30%) |
| Platelets | 3 (10%) | 1 (10%) |
| Plasma | 2 (7%) | 2 (20%) |
| None | 14 (45%) | 7 (70%) |
| Daclizumab | 2 (7%) | – |
| Basiliximab | 23 (74%) | 10 (100%) |
| Methylprednisolone | 6 (19%) | – |
| Postoperative mechanical ventilation (days) | 1 (1–2) | 2.5 (1–3.3) |
| ICU length of stay (days) | 4 (2–5) | 5.5 (4.5–9.8) |
| Days in the general ward after surgery | 11 (7–17) | 20 (5–34) |
| Total hospital days after surgery | 17 (12–24) | 27 (10–48) |
| Graft failure | 1 (3.2%) | – |
| Death with functional graft | 2 (6.4%) | 2 (20%) |
| Data are presented as median±interquartile range, mean±standard deviation, and n (%). ICU – Intensive Care Unit. | ||